X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Abbott India with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TEVA PHARMA (Israel) - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   TEVA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
TEVA PHARMA
Dec-13
ABBOTT INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6,0152,683-   
Low Rs3,7072,331-   
Sales per share (Unadj.) Rs1,236.91,539.8-  
Earnings per share (Unadj.) Rs122.296.2-  
Cash flow per share (Unadj.) Rs129.0220.7-  
Dividends per share (Unadj.) Rs35.0084.21-  
Dividend yield (eoy) %0.73.4 21.4%  
Book value per share (Unadj.) Rs521.21,710.5-  
Shares outstanding (eoy) m21.25848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.91.6 241.4%   
Avg P/E ratio x39.826.1 152.7%  
P/CF ratio (eoy) x37.711.4 331.7%  
Price / Book Value ratio x9.31.5 636.3%  
Dividend payout %28.687.5 32.7%   
Avg Mkt Cap Rs m103,2962,125,868 4.9%   
No. of employees `0003.044.9 6.6%   
Total wages/salary Rs m3,3700-   
Avg. sales/employee Rs Th8,891.829,052.9 30.6%   
Avg. wages/employee Rs Th1,140.00-   
Avg. net profit/employee Rs Th878.31,814.9 48.4%   
INCOME DATA
Net Sales Rs m26,2841,305,784 2.0%  
Other income Rs m5040-   
Total revenues Rs m26,7891,305,784 2.1%   
Gross profit Rs m3,665357,590 1.0%  
Depreciation Rs m144105,548 0.1%   
Interest Rs m825,648 0.0%   
Profit before tax Rs m4,017226,394 1.8%   
Minority Interest Rs m01,028 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-148,615 0.0%   
Tax Rs m1,421-2,764 -51.4%   
Profit after tax Rs m2,59681,571 3.2%  
Gross profit margin %13.927.4 50.9%  
Effective tax rate %35.4-1.2 -2,897.2%   
Net profit margin %9.96.2 158.1%  
BALANCE SHEET DATA
Current assets Rs m14,446881,922 1.6%   
Current liabilities Rs m4,725769,110 0.6%   
Net working cap to sales %37.08.6 428.1%  
Current ratio x3.11.1 266.6%  
Inventory Days Days5191 56.6%  
Debtors Days Days2096 20.4%  
Net fixed assets Rs m1,113426,498 0.3%   
Share capital Rs m2133,214 6.6%   
"Free" reserves Rs m10,8080-   
Net worth Rs m11,0761,450,478 0.8%   
Long term debt Rs m0667,676 0.0%   
Total assets Rs m16,2412,984,135 0.5%  
Interest coverage x497.09.8 5,057.1%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.60.4 369.9%   
Return on assets %16.03.6 446.3%  
Return on equity %23.45.6 416.8%  
Return on capital %36.34.9 737.0%  
Exports to sales %0.60-   
Imports to sales %12.60-   
Net fx Rs m-3,6590-   
CASH FLOW
From Operations Rs m2,514208,074 1.2%  
From Investments Rs m-800-73,729 1.1%  
From Financial Activity Rs m-803-249,599 0.3%  
Net Cashflow Rs m912-115,254 -0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.28 Rs / USD

Compare ABBOTT INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ABBOTT INDIA With: SUVEN LIFE  ORCHID PHARMA LTD  SANOFI INDIA  PLETHICO PHARMA  VENUS REMEDIES  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 16, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - PFIZER COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS